Keywords: genentech, lucentis, denied, fast-track, status, biotechnology, major

Genentech's Lucentis denied fast-track status

Article | 19 September 2005

Print This

US biotechnology major Genentech says that it plans to file a complete Biologics License Application for its investigational drug Lucentis ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in